Co-Diagnostics, Inc.
CODX
$0.375
$0.01985.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -37.64M | -41.28M | -37.57M | -38.89M | -35.33M |
| Total Depreciation and Amortization | 1.38M | 1.33M | 1.28M | 1.25M | 1.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.35M | 12.06M | 10.65M | 9.07M | 6.38M |
| Change in Net Operating Assets | 2.75M | 2.19M | 1.40M | 3.92M | 5.64M |
| Cash from Operations | -29.16M | -25.70M | -24.24M | -24.65M | -22.08M |
| Capital Expenditure | -748.30K | -1.14M | -1.20M | -1.59M | -1.37M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.82M | 27.56M | 25.79M | 43.86M | 16.75M |
| Cash from Investing | 17.07M | 26.42M | 24.59M | 42.28M | 15.39M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 103.90K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -159.70K | -326.00K | -881.70K | -1.36M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 103.90K | -159.70K | -326.00K | -881.70K | -1.36M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.98M | 557.80K | 28.10K | 16.74M | -8.06M |